Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
DeepMatter
DeepMatter
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Cloud based smart chemistry platform
This single platform allows reaction data to be compiled from multiple data sources to provide a cleansed, harmonised, and categorised repository
Research & Development
DeepMatter provides software platform for University of Cambridge
DigitalGlassware is a cloud-based platform designed to allow scientists to bring together digitised synthesis protocols
Finance
DeepMatter appointments Non-Executive Director
The company will seek to leverage his knowledge to further develop its data platforms and ensure they meet the needs of the pharmaceutical industry
Research & Development
DeepMatter collaborates with universities on manufacturing
The company will provide its DigitalGlassware software, a cloud-based platform that allows chemists to share data in real-time and digitally enable scale-up of advanced nanoparticle products
Manufacturing
AstraZeneca chooses DeepMatter for optimisation of compound synthesis
DeepMatter has joined forces with AstraZeneca to improve productivity using digital equipment enabled with machine learning and AI
Subscribe now